Cited 0 times in 
Cited 0 times in 
Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Myer, Nicole M. | - |
| dc.contributor.author | Shitara, Kohei | - |
| dc.contributor.author | Chung, Hyun Cheol | - |
| dc.contributor.author | Lordick, Florian | - |
| dc.contributor.author | Kelly, Ronan J. | - |
| dc.contributor.author | Szabo, Zsolt | - |
| dc.contributor.author | Cao, Z. Alexander | - |
| dc.contributor.author | Leong, Stephen | - |
| dc.contributor.author | Ilson, David H. | - |
| dc.contributor.author | Weichert, Wilko | - |
| dc.date.accessioned | 2023-06-02T00:53:46Z | - |
| dc.date.available | 2023-06-02T00:53:46Z | - |
| dc.date.created | 2023-03-30 | - |
| dc.date.issued | 2022-08 | - |
| dc.identifier.issn | 0171-5216 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194503 | - |
| dc.description.abstract | Despite new therapeutic options, advanced gastric cancer remains associated with a poor prognosis compared with other cancers. Recent gains in the treatment of gastric cancer were accompanied by the identification of novel biomarkers associated with various cellular pathways and corresponding diagnostic technologies. It is expected that the standardization of clinical workflow and technological refinements in biomarker assessment will support greater personalization and further improve treatment outcomes. In this article, we review the current state of prognostic and predictive biomarkers in gastric cancer. | - |
| dc.description.statementOfResponsibility | restriction | - |
| dc.language | English, German | - |
| dc.publisher | Springer-Verlag | - |
| dc.relation.isPartOf | Journal of Cancer Research and Clinical Oncology | - |
| dc.relation.isPartOf | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
| dc.contributor.googleauthor | Myer, Nicole M. | - |
| dc.contributor.googleauthor | Shitara, Kohei | - |
| dc.contributor.googleauthor | Chung, Hyun Cheol | - |
| dc.contributor.googleauthor | Lordick, Florian | - |
| dc.contributor.googleauthor | Kelly, Ronan J. | - |
| dc.contributor.googleauthor | Szabo, Zsolt | - |
| dc.contributor.googleauthor | Cao, Z. Alexander | - |
| dc.contributor.googleauthor | Leong, Stephen | - |
| dc.contributor.googleauthor | Ilson, David H. | - |
| dc.contributor.googleauthor | Weichert, Wilko | - |
| dc.identifier.doi | 10.1007/s00432-021-03902-1 | - |
| dc.relation.journalcode | J01283 | - |
| dc.identifier.eissn | 1432-1335 | - |
| dc.identifier.pmid | 35551464 | - |
| dc.subject.keyword | Gastric cancer | - |
| dc.subject.keyword | Biomarkers | - |
| dc.subject.keyword | Programmed death ligand 1 | - |
| dc.subject.keyword | Tumor mutational burden | - |
| dc.subject.keyword | Microsatellite instability | - |
| dc.contributor.alternativeName | Chung, Hyun Cheol | - |
| dc.contributor.affiliatedAuthor | Chung, Hyun Cheol | - |
| dc.identifier.scopusid | 2-s2.0-85130193223 | - |
| dc.identifier.wosid | 000795175100001 | - |
| dc.citation.volume | 148 | - |
| dc.citation.number | 8 | - |
| dc.citation.startPage | 2023 | - |
| dc.citation.endPage | 2043 | - |
| dc.identifier.bibliographicCitation | Journal of Cancer Research and Clinical Oncology, Vol.148(8) : 2023-2043, 2022-08 | - |
| dc.identifier.rimsid | 78281 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | Gastric cancer | - |
| dc.subject.keywordAuthor | Biomarkers | - |
| dc.subject.keywordAuthor | Programmed death ligand 1 | - |
| dc.subject.keywordAuthor | Tumor mutational burden | - |
| dc.subject.keywordAuthor | Microsatellite instability | - |
| dc.subject.keywordPlus | TUMOR MUTATIONAL BURDEN | - |
| dc.subject.keywordPlus | GASTROESOPHAGEAL JUNCTION CANCER | - |
| dc.subject.keywordPlus | MICROSATELLITE INSTABILITY | - |
| dc.subject.keywordPlus | OPEN-LABEL | - |
| dc.subject.keywordPlus | PLUS CHEMOTHERAPY | - |
| dc.subject.keywordPlus | 1ST-LINE PEMBROLIZUMAB | - |
| dc.subject.keywordPlus | PD-L1 EXPRESSION | - |
| dc.subject.keywordPlus | POOR-PROGNOSIS | - |
| dc.subject.keywordPlus | SINGLE-AGENT | - |
| dc.subject.keywordPlus | HER2 STATUS | - |
| dc.type.docType | Review | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.relation.journalResearchArea | Oncology | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.